Market closedNon-fractional

Shattuck Labs/STTK

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Shattuck Labs

Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.

Ticker

STTK

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Austin, United States

Employees

75

Shattuck Labs Metrics

BasicAdvanced
$176M
Market cap
-
P/E ratio
-$1.91
EPS
1.86
Beta
-
Dividend rate
$176M
1.86
9.148
8
2.479
3.116
-34.74%
-59.40%
60.825
1.35
1.35
-2.317
282.93%
-17.65%
-33.49%
3.07%

What the Analysts think about Shattuck Labs

Analyst Ratings

Majority rating from 6 analysts.
Buy

Shattuck Labs Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1,681.81% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.1M
57.14%
Net income
-$19M
5.11%
Profit margin
-1,681.81%
-33.11%

Shattuck Labs Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 17.26%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.50
-$0.65
-$0.41
-$0.37
-
Expected
-$0.52
-$0.52
-$0.57
-$0.45
-$0.41
Surprise
-3.33%
25.20%
-27.84%
-17.26%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Shattuck Labs stock?

Shattuck Labs (STTK) has a market cap of $176M as of July 06, 2024.

What is the P/E ratio for Shattuck Labs stock?

The price to earnings (P/E) ratio for Shattuck Labs (STTK) stock is 0 as of July 06, 2024.

Does Shattuck Labs stock pay dividends?

No, Shattuck Labs (STTK) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Shattuck Labs dividend payment date?

Shattuck Labs (STTK) stock does not pay dividends to its shareholders.

What is the beta indicator for Shattuck Labs?

Shattuck Labs (STTK) has a beta rating of 1.86. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Shattuck Labs stock

Buy or sell Shattuck Labs stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing